Inosi Therapeutics develop therapies to address fibrosis.
Inosi Therapeutics has raised $968K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Inosi Therapeutics's investors include IP Group, MTPConnect, Monash University.
Inosi Therapeutics is headquartered in Southbank, Australia.
Inosi Therapeutics develop therapies to address fibrosis.
Inosi Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inosi Therapeutics — Funding & Investors." VCBacked, June 20, 2025, https://www.vcbacked.co/company/inosi-therapeutics. Accessed September 29, 2026.
VCBacked. (2025). Inosi Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/inosi-therapeutics
{{cite web |title=Inosi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inosi-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated